Eur Rev Med Pharmacol Sci 2019; 23 (12): 5402-5412
DOI: 10.26355/eurrev_201906_18209

Meta-analysis of the impact on early and late mortality of TAVI compared to surgical aortic valve replacement in high and low-intermediate surgical risk patients

D. Sergi, M.C. Acconcia, S. Muscoli, M.A. Perrone, V. Cammalleri, M. Di Luozzo, M. Marchei, M.F. Giannoni, F. Barillà, C. Gaudio, M. Chiocchi, F. Romeo, Q. Caretta

Department of Cardiovascular Disease, University of Rome “Tor Vergata”, Rome, Italy. qcaretta@unifi.it


OBJECTIVE: We studied the impact of transcatheter aortic valve implantation (TAVI) compared to the surgical aortic valve replacement (SAVR) on 30-day and one-year mortality from randomized controlled trials (RCTs) in patients with severe aortic stenosis at high or low-intermediate surgical risk.
MATERIALS AND METHODS: All RCTs were retrieved through PubMed computerized database and the site https://www.clinicaltrials.gov from January 2010 until March 31st, 2019. The absolute risk reduction (RD) with the 95% confidence interval (CI) was used to assess the effectiveness of the intervention under comparison. We evaluated overall mortality rates at 30-day and one-year follow-up in the comparison between TAVI vs. SAVR. We also evaluated the role played by the site access for TAVI performed through the femoral or subclavian artery (TV-TAVI) vs. SAVR, or transapically (TA-TAVI) vs. SAVR.
RESULTS: In the “as-treated population” the overall 30-day mortality was significantly lower in TAVI (p=0.03) with respect to SAVR. However, the analysis for TAVI subgroups showed that 30-day mortality was (1) significantly lower in TV-TAVI vs. SAVR (p=0.006), (2) increased, not significantly, in TA-TAVI vs. SAVR (p=0.62). No significant differences were found between TAVI vs. SAVR at one-year follow-up.
CONCLUSIONS: The results of our meta-analysis suggest that TV-TAVI is a powerful tool in the treatment of severe aortic stenosis at high or low-intermediate surgical risk, with a significant lower mortality with respect to SAVR. On the contrary, SAVR seems to provide better results than TA-TAVI.

Free PDF Download

To cite this article

D. Sergi, M.C. Acconcia, S. Muscoli, M.A. Perrone, V. Cammalleri, M. Di Luozzo, M. Marchei, M.F. Giannoni, F. Barillà, C. Gaudio, M. Chiocchi, F. Romeo, Q. Caretta
Meta-analysis of the impact on early and late mortality of TAVI compared to surgical aortic valve replacement in high and low-intermediate surgical risk patients

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 12
Pages: 5402-5412
DOI: 10.26355/eurrev_201906_18209